- Home
- ARQ vs FENC Comparison
ARQ vs FENC Comparison
Compare ARQ & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- FENC
- Stock Information
- Founded
- ARQ 1996
- FENC 1996
- Country
- ARQ United States
- FENC United States
- Employees
- ARQ N/A
- FENC N/A
- Industry
- ARQ
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARQ
- FENC Health Care
- Exchange
- ARQ NYSE
- FENC Nasdaq
- Market Cap
- ARQ 147.8M
- FENC 156.9M
- IPO Year
- ARQ N/A
- FENC 2001
- Fundamental
- Price
- ARQ $3.65
- FENC $5.63
- Analyst Decision
- ARQ Strong Buy
- FENC Strong Buy
- Analyst Count
- ARQ 1
- FENC 2
- Target Price
- ARQ $9.00
- FENC $14.00
- AVG Volume (30 Days)
- ARQ 284.1K
- FENC 78.1K
- Earning Date
- ARQ 05-07-2025
- FENC 05-13-2025
- Dividend Yield
- ARQ N/A
- FENC N/A
- EPS Growth
- ARQ N/A
- FENC N/A
- EPS
- ARQ N/A
- FENC N/A
- Revenue
- ARQ $108,959,000.00
- FENC $47,538,000.00
- Revenue This Year
- ARQ $19.26
- FENC $2.68
- Revenue Next Year
- ARQ $24.97
- FENC $71.63
- P/E Ratio
- ARQ N/A
- FENC N/A
- Revenue Growth
- ARQ 9.86
- FENC 123.69
- 52 Week Low
- ARQ $3.34
- FENC $3.96
- 52 Week High
- ARQ $8.26
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- ARQ 38.82
- FENC 49.40
- Support Level
- ARQ $3.58
- FENC $5.51
- Resistance Level
- ARQ $3.86
- FENC $5.75
- Average True Range (ATR)
- ARQ 0.27
- FENC 0.33
- MACD
- ARQ 0.05
- FENC 0.09
- Stochastic Oscillator
- ARQ 56.36
- FENC 88.79
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.